Temazepam and Eczema - a phase IV clinical study of FDA data

Summary:

Eczema is found among people who take Temazepam, especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Temazepam and have Eczema. It is created by eHealthMe based on reports of 37,289 people who have side effects when taking Temazepam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

37,289 people reported to have side effects when taking Temazepam.
Among them, 56 people (0.15%) have Eczema.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 38,640 Temazepam users for its effectiveness, alternative drugs and more.

What is Eczema?

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters) is found to be associated with 2,484 drugs and 1,817 conditions by eHealthMe.

Number of Temazepam and Eczema reports submitted per year:

Time on Temazepam when people have Eczema *:

Gender of people who have Eczema when taking Temazepam *:

female: 69.23 %
male: 30.77 %

Age of people who have Eczema when taking Temazepam *:

Common drugs people take besides Temazepam *:

Common side effects people have besides Eczema *:

Stress And Anxiety: 24 people, 42.86%
Pain: 23 people, 41.07%
Breathing Difficulty: 21 people, 37.50%
Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 35.71%
Metastases To Bone (cancer spreads to bone): 20 people, 35.71%
Fever: 20 people, 35.71%
Back Pain: 20 people, 35.71%
Constipation: 19 people, 33.93%
Bone Pain: 18 people, 32.14%
Eating Disorder: 18 people, 32.14%

Common conditions people have *:

Breast Cancer Metastatic: 16 people, 28.57%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 13 people, 23.21%
Breast Cancer: 13 people, 23.21%
Pain: 5 people, 8.93%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 8.93%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 4 people, 7.14%
High Blood Pressure: 3 people, 5.36%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 5.36%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 5.36%
Asthma: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Temazepam and have Eczema?

Check whether Eczema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Eczema and when was it recovered:

Eczema in Temazepam

Expand to all the drugs that have ingredients of temazepam:

Eczema and drugs with ingredients of temazepam (71 reports)

Alternative drugs to, pros and cons of Temazepam:

Temazepam (38,640 reports)

Common Temazepam side effects:

Fatigue (feeling of tiredness): 2,883 reports
Pain: 2,424 reports
Drug ineffective: 2,228 reports
Stress and anxiety: 2,181 reports
Headache (pain in head): 2,050 reports
Breathing difficulty: 2,024 reports

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Eczema treatments and more:

Eczema (41,092 reports)

COVID vaccines that are related to Eczema:

Common drugs associated with Eczema:

All the drugs that are associated with Eczema:

Eczema (2,484 drugs)

Common conditions associated with Eczema:

All the conditions that are associated with Eczema:

Eczema (1,817 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temazepam) and Temazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.